Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (8): 858-865.
DOI: 10.19803/j.1672-8629.20230118
Previous Articles Next Articles
YIN Yuling1, HU Chujuan1, ZHANG Xiaomeng1,2, WANG Yu1,2, ZHANG Bing1,2,*, LIN Zhijian1,2
Received:
2023-03-01
Online:
2023-08-15
Published:
2023-08-07
CLC Number:
YIN Yuling, HU Chujuan, ZHANG Xiaomeng, WANG Yu, ZHANG Bing, LIN Zhijian. Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 858-865.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20230118
[1] SMRKE A, ANDERSON PM, GULIA A, et al.Future directions in the treatment of osteosarcoma[J]. Cells, 2021, 10(1): 172. [2] SINGAL PK, ILISKOVIC N.Doxorubicin-induced cardiomyopathy[J]. N Engl J Med, 1998, 339(13): 900-905. [3] FELKER GM, THOMPSON RE, HARE JM, et al.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy[J]. N Engl J Med, 2000, 342(15): 1077-1084. [4] LIU TS, LI W.Adverse reactions and treatment of anti-tumor drugs[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2008, 5(6): 368-372. [5] China Society of Clinical Oncology Guidelines Working Committee. China Society of Clinical Oncology (CSCO) Guidelines for the prevention and treatment of anthracycline cardiotoxicity[M]. Beijing: People's Health Publishing House, 2020: 6-28. [6] CARDINALE D, COLOMBO A, BACCHIANI G, et al.Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy[J]. Circulation, 2015, 131(22): 1981-1988. [7] YANG HF, HUANG PN, LIU ZH, et al.A preliminary study on tcm syndromes and syndrome elements of anthracyclines acute cardiotoxicity[J]. Journal of Emergency in Traditional Chinese Medicine(中国中医急症), 2020, 29(12): 2092-2096. [8] WU XF, ZUO MH, DENG LP,et al.TCM treatment and clinical experience of anthracycline-induced cardiac damage[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2021, 48(4): 65-68. [9] LIN ZJ, ZHANG B, LI LY.The medication history and pharmacological research progress of chicory, a national medicine[C]. Proceedings of the 2014 International Health Service Summit Forum on Traditional Chinese Medicine, 2014: 50-55. [10] VISHWADEEP S, GHANSHYAM J, AMOL M, et al.Cichorium intybus inhibits doxorubicin - induced myocardial fibrosis in Wistar Rats Via inflammatory markers and collagen Repression[J]. European Journal of Medicinal Plants, 2021, 32(2): 51-61. [11] ELGHARABAWY RM, ALHOWAIL AH, EMARA AM, et al.The impact of chicory (Cichoriumintybus L.) on hemodynamic functions and oxidative stress in cardiac toxicity induced by lead oxide nanoparticles in male rats[J]. Biomed Pharmacother, 2021, 5(137): 111324. [12] SEDIGHI M, GHORBANZADEH V, ABASZADEH S, et al.Up-regulation of chemokine receptor type 4 expression in the ischemic reperfused heart by alcoholic extract of Cichorium intybus rescue the heart from ischemia injury in male rat[J]. Journal of Pharmacy and Pharmacology, 2021, 73(10): 1351-1360. [13] MANJU S, AIMAN A, SHRIDHAR D, et al.Cichorium intybus attenuates streptozotocin induced diabetic cardiomyopathy via inhibition of oxidative stress and inflammatory response in rats[J]. Interdisciplinary Toxicology, 2019, 12(3): 111-119. [14] EPURE A, PÂRVU AE, VLASE L, et al. Cardioprotective and nephroprotective activity of romanian chicory extract[J]. Plants, 2020, 10(1): 64. [15] Nayeemunnisa and Rani MK. Cardioprotective effect of Cichorium intybus in ageing myocardium of albino rats[J]. Current Science, 2003, 84(7): 941-943. [16] SU D, LI Y, ZHANG JJ, et al.Protective effect of chicory polysaccharide on myocardial ischemia-reperfusion injury in streptomycin induced diabetes rats[J]. Heilongjiang Medicine Journal(黑龙江医药), 2011, 24(1): 112-113. [17] LI Y, LIU XS, YANG X, et al.The protective effect of chicory polysaccharides on diabetic-resulted myocardial ischemia-reperfusion injury in rats[J].Chinese Journal of Gerontology(中国老年学杂志), 2013, 33(2): 330-331. [18] LIU JH, WU H, XING QW, et al.Effect of cichoric acid on hematology indicators and myocardial in a hypoxic environment in SD rats[J]. Feed Research(饲料研究), 2021, 44(23): 73-77. [19] LI YL.The study of protective effects chicoric acid on myocardial injury in rats with sepsis[D]. Nanchang: Nanchang University, 2019. [20] LI YL, YAO P, QI H, et al.Effects of cichoric acid on oxidative stress and its relationship with Nrf2 signal pathway in septic rats with myocardial injury[J]. Chinese Journal of Anesthesiology(中华麻醉学杂志), 2021, 41(4): 491-495. [21] LIU JH.Study of Echinacea purpurea extract cichoric acid on hypoxic adaptability of SD rats[D]. Xining: Qinghai University, 2022. [22] YUEERGULI Y, ASIYA H, YIN TT.Effect of chicoric acid on myocardial ischemia reperfusion injury in mice[J]. Journal of Medical Molecular Biology(医学分子生物学杂志), 2021, 18(4): 298-303. [23] CHEN MP, WANG YX, YAO RM, et al.Mechanisms of Qingkailing soft capsules against coronavirus pneumonia based on network pharmacology and experimental verification[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(3): 253-257. [24] ZHANG ZS, LU YL, GAO YF, et al.Research progress of bitter substances in [25] FAN H, CHEN J, LIANG QY,et al.Advance in studies on chemical constituents of Cichorii Herba and their pharmacological effects[J]. Chinese Traditional and Herbal Drugs(中草药), 2016, 47(4): 680-688. [26] ZHU CS, LIN ZJ, ZHANG B, et al.Qualitative and quantitative analysis of chicory root by LC/MS and HPLC[J]. Journal of Beijing University of Traditional Chinese Medicine(北京中医药大学学报), 2016, 39(3): 247-251. [27] LUO Y, LIU S, FANG LY, et al.Contents determination of effective components in cichorium intybus by HPLC[J]. West China Journal of Pharmaceutical Sciences(华西药学杂志), 2007, 6: 671-672. [28] ZHOU J.Comprehensive evaluation of the quality of aboveground medicinal materials of chicory[D]. Beijing: Beijing University of Chinese Medicine, 2014. [29] PEI TX, XU CQ, LI B, et al.Protective effect of quercetin against adriamycin-induced cardiotoxicity and its mechanism in mice[J]. Acta Pharmaceutica Sinica(药学学报), 2007, 42(10): 1029-1033. [30] SHI YY, YANG R, ZHANG Y, et al.Research on the mechanism of luteolin against H9c2 cardiomyocyte injury through MIEF1[J]. Natural Product Research and Development, 2020, 32(5): 820-825. [31] CHOI EH, CHANG HJ, CHO JY, et al.Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities[J]. Food Chem Toxicol,2007,45(10):1873-1881. [32] DU XF, GAO J, ZHANG H.Kaempferol enhances the anticancer effect of doxorubicin in breast cancer models[J]. Chinese Journal of Anatomy(解剖学杂志), 2022, 45(2): 135-141,207. [33] HE P, WANG YJ.Progress in the pathogenesis and diagnosis and treatment of anthracycline related cardiotoxicity[J]. Modern Medicine and Health Research Electronic Journal(现代医学与健康研究电子杂志), 2020, 4(8): 114-117. [34] ZHANG L, ZHAO H, ZHANG X, et al.Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat[J]. Brain Res Bull, 2013, 7(96): 45-53. [35] CHE RQ, CUI XJ, MA CM.Pioglitazone ameliorates doxorubicin-induced cardiotoxicity through PI3K/AKT pathway[J].Medical Journal of Wuhan University(武汉大学学报医学版), 2021, 42(3): 402-406. [36] LYU J, YANG SX, HAU XF, et al.Sinigrin protects against doxorubicin-induced cardiotoxicity via the p38/JNK MAPK pathway[J].International Journal of Cardiovascular Disease, 2020, 47(1): 48-51. [37] ZHANG FH, HAO JF, ZHANG ZY, et al.Impacts of cichoric acid on neuronal apoptosis and inflammatory response in ischemic stroke rats by regulating p38 MAPK/ NF- [38] ZHU D, WANG Y, DU Q, et al.Cichoric acid reverses insulin resistance and suppresses inflammatory Responses in the Glucosamine-Induced HepG2 cells[J]. J Agric Food Chem, 2015, 63(51):10903-10913. [39] ICHIKAWA Y, GHANEFAR M, BAYEVA M, et al.Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation[J].J Clin Invest, 2014, 124(2):617-630. [40] ARUNACHALAM S, NAGOORMEERAN M, AZIMULLAH S, et al.Nerolidolattenuates oxidative stress, inflammation,and apoptosis by modulating Nrf2/MAPK signaling pathways in doxorubicin-induced acute cardiotoxicity in rats[J]. Antioxidants (Basel, Switzerland), 2021, 10(6): 984. [41] LI J, WANG PY, LONG NA, et al.p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities[J]. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116(39): 19626-19634. [42] LISA FD, GIORGIO M, FERDINANDY P, et al New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases[J]. Br J Pharmacol, 2017, 174(12): 1690-1703. [43] ZHANG J, SUN Z, LIN N, et al.Fucoidan from fucus vesiculosus attenuates doxorubicin-induced acute cardiotoxicity by regulating JAK2/STAT3-mediated apoptosis and autophagy[J]. Biomed Pharmacother, 2020, 10(130): 110534. [44] LI B, ZHAO X, ZHANG L, et al.Emodin interferes with AKT1-mediated dna damage and decreases resistance of breast cancer cells to doxorubicin[J] . Frontiers in Oncology, 2021, 2(11): 588533. [45] QIN AQ, LIANG JY, LI XF, et al.Acute cardiotoxicity induced by doxorubicin in mice of different strains: a comparative study[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2021, 37(6): 161-166. [46] WANG XL, CHEN YN, HUANG HQ, et al.Study on astragaloside IV alleviating the cardiotoxicity caused by doxorubicin by inhibiting MerTK[J].Journal of Bengbu Medical College(蚌埠医学院学报), 2021, 46(6): 717-721. [47] HAILIMAN YLH, WULIYA YM, WANG XW.Stereolal study of protective effect of glycosides of cistanche on mitochondria of cardiac muscle against adriamycin[J].Journal of Xinjiang Medical University(新疆医科大学学报), 2004(2): 128-130. [48] XU BP.Study on the effect and mechanism of buguzhiding in preventing adr myocardial injury[D]. Xi'an: Northwest University, 2021. [49] CALEMA TU, YAP SC, GELEIJNES ML, et al.Early detection of leftventricular dysfunction by doppler tissue imaging and N-teminal-pro-B-type natriuretic peptide in patients with synptomatic serene aor-tic stenosis[J].J Am Soc Echocardiogr, 2008, 21(3): 257-261. [50] LIN LY, LIN YS.The value of serum prealbumin combined with N-terminal B-type natriuretic peptide precursor in evaluating the severity and prognosis of chronic heart failure[J]. Chronic Pathematology Journal(慢性病学杂志), 2021, 22(3): 446-448. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan. Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50. |
[4] | ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan. The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54. |
[5] | ZHANG Liangliang, HU Changkun, WU Zekun, ZHOU Wei, LIAO Zebin, GAO Yue. Protective effect and mechanism of dimethyl fumarate against intestinal radiation injury [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 83-88. |
[6] | YANG Zhenzhen, CHANG Cheng, GAO Na, ZHANG Xiaolin, SONG Yinsen, LIU Ying, FAN Tianli. Molecular mechanism of luteolin for inhibiting esophageal squamous cell carcinoma based on network pharmacology and in vitro studies [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 992-1001. |
[7] | MEI Yu, ZHU Yue, ZHANG Huiting, XIAO Chengrong, GAO Yue, MA Zengchun. Protective mechanism of Chinese medicine compound CB001 against low dose radiation based on network pharmacology and experimental verification [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 872-879. |
[8] | YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping. Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884. |
[9] | SHEN Ningning, LIU Yufu, RU Yi, SHI Zhuo, YANG Chunqi, NI Zhexin, XIAO Chengrong, MA Zengchun, WANG Yuguang, GAO Yue. Antifatigue effect of ophiopogonin D on exhaustive swimming in mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 749-753. |
[10] | WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei. Acute toxicity of proline Danshensu borneol ester in mice [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757. |
[11] | ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin. Preclinical safety evaluation of Jinkui Shenqi pills [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782. |
[12] | SU Yuefen, ZHENG Jingrou, GONG He, XIE Guangtong, ZHANG Jie, SAI Chunmei. Formability and mechanism of breast nodule pain-alleviating gel plaster for the treatment of breast hyperplasia [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 783-790. |
[13] | HUANG Wei, WU Ruiqing, SUN Hua, SHI Jiangong, LIU Qian. Reversal of multidrug resistance in human oral epithelial cancer cells KBV200 by a natural product [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 403-408. |
[14] | CHEN Mengping, WANG Yaxin, YAO Rongmei, BAO Lei, ZHAO Ronghua, SUN Jing, GENG Zihan, BAO Yanyan, DAI Min, GUO Shanshan, CUI Xiaolan. Mechanisms of Qingkailing soft capsules against coronavirus pneumonia based on network pharmacology and experimental verification [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 253-257. |
[15] | WANG Shan, HUANG Jukai, WU Honghui, WEN Yalu, ZHANG Li, WANG Jianhua, YANG Xiaohui. Evaluation of a KKAy animal model of type 2 diabetes mellitus combined with nonalcoholic fatty liver disease [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 273-276. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||